Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

The aim of this study was to identify baseline peripheral blood biomarkers associated with clinical outcome in patients with NSCLC treated with nivolumab. Univariable and multivariable analyses were performed retrospectively for 134 patients with advanced or recurrent NSCLC treated with nivolumab to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thoracic oncology 2018-01, Vol.13 (1), p.97-105
Hauptverfasser:	Tanizaki, Junko, Haratani, Koji, Hayashi, Hidetoshi, Chiba, Yasutaka, Nakamura, Yasushi, Yonesaka, Kimio, Kudo, Keita, Kaneda, Hiroyasu, Hasegawa, Yoshikazu, Tanaka, Kaoru, Takeda, Masayuki, Ito, Akihiko, Nakagawa, Kazuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - blood Adenocarcinoma - drug therapy Adenocarcinoma - pathology Aged Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - therapeutic use Carcinoma, Non-Small-Cell Lung - blood Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Squamous Cell - blood Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Female Follow-Up Studies Humans Leukocytes - pathology Lung Neoplasms - blood Lung Neoplasms - drug therapy Lung Neoplasms - pathology Lymphocytes - pathology Male Neutrophils - pathology Nivolumab Non–small cell lung cancer Peripheral blood biomarker Predictive factor Prognosis Prognostic factor Retrospective Studies Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!